Drug Name Sumycin

On 23 October 2008, the European Medicines Agency (EMEA) issued a press release stating its Committee for Medical Products for Human Use (CHMP) had concluded the benefits of Acomplia no longer outweighed its risks, and subsequently recommended the product be suspended from the UK market. Sanofi-Aventis later released a press statement stating the drug had been suspended. Approval of the drug was officially withdrawn by the EMEA on 16 January 2009.
The study also revealed that the screening ability of HbA1c in non-Hispanic Americans differed by race. For example, researchers observed more false- negative results and fewer false-positive results in whites than blacks.

 

Generic versions are available in Canada and were FDA approved in September 2006. Mylan Pharmaceuticals was recently granted final approval for generic topiramate 25, 100, and 200 mg tablets and sprinkle capsules by the FDA for sale in the US. 50 mg tablets were granted tentative approval. The last patent for topiramate in the U.S. was for pediatric use; this patent expired on February 28, 2009.
Amoxicillin (INN), formerly amoxycillin (BAN), amoxycillin (cilamox) in Australia[1], abbreviated Amox,Tormoxin (in India), is a moderate-spectrum, bacteriolytic, b-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other b-lactam antibiotics. It is also a treatment for cystic acne.